- Home
- NOTV vs RAND Comparison
NOTV vs RAND Comparison
Compare NOTV & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- RAND
- Stock Information
- Founded
- NOTV 1974
- RAND 1969
- Country
- NOTV United States
- RAND United States
- Employees
- NOTV N/A
- RAND N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- RAND Finance: Consumer Services
- Sector
- NOTV Health Care
- RAND Finance
- Exchange
- NOTV Nasdaq
- RAND Nasdaq
- Market Cap
- NOTV 40.4M
- RAND 47.5M
- IPO Year
- NOTV 1997
- RAND N/A
- Fundamental
- Price
- NOTV $1.67
- RAND $16.48
- Analyst Decision
- NOTV Buy
- RAND
- Analyst Count
- NOTV 3
- RAND 0
- Target Price
- NOTV $5.25
- RAND N/A
- AVG Volume (30 Days)
- NOTV 183.0K
- RAND 3.2K
- Earning Date
- NOTV 08-08-2024
- RAND 11-04-2024
- Dividend Yield
- NOTV N/A
- RAND 7.04%
- EPS Growth
- NOTV N/A
- RAND 72.67
- EPS
- NOTV N/A
- RAND 4.19
- Revenue
- NOTV $501,062,000.00
- RAND $7,874,601.00
- Revenue This Year
- NOTV N/A
- RAND N/A
- Revenue Next Year
- NOTV $8.69
- RAND N/A
- P/E Ratio
- NOTV N/A
- RAND $4.11
- Revenue Growth
- NOTV N/A
- RAND 13.24
- 52 Week Low
- NOTV $1.23
- RAND $12.50
- 52 Week High
- NOTV $11.42
- RAND $19.60
- Technical
- Relative Strength Index (RSI)
- NOTV 54.83
- RAND 40.74
- Support Level
- NOTV $1.23
- RAND $16.18
- Resistance Level
- NOTV $1.63
- RAND $17.27
- Average True Range (ATR)
- NOTV 0.16
- RAND 0.63
- MACD
- NOTV 0.05
- RAND -0.25
- Stochastic Oscillator
- NOTV 62.86
- RAND 9.20
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, diversified management company. The firm's investment objectives is to maximize the total return to the shareholders with current income combined with capital appreciation. Some of its portfolios include lumious, and GiveGab among others.